(Q72967269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

1 reference

1 reference

S J Falk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T S Maughan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

V M Laurence

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Lamont

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

D Boote

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J M Ford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

R J Osborne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

N M Bleehen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

85-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980852-0

7 January 2021

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980852-0

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980852-0

7 January 2021

Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980852-0

7 January 2021

Identification of new drugs in pretreated patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980852-0

7 January 2021

10.1016/S0936-6555(05)80852-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8386937%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference